ClearPoint Neuro, Inc. (CLPT) NASDAQ
12.37
-0.27(-2.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
12.37
-0.27(-2.14%)
Currency In USD
| Previous Close | 12.64 |
| Open | 12.43 |
| Day High | 12.45 |
| Day Low | 11.97 |
| 52-Week High | 30.1 |
| 52-Week Low | 8.27 |
| Volume | 527,643 |
| Average Volume | 685,644 |
| Market Cap | 370.97M |
| PE | -12.37 |
| EPS | -1 |
| Moving Average 50 Days | 10.77 |
| Moving Average 200 Days | 14.15 |
| Change | -0.27 |
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
GlobeNewswire Inc.
Oct 17, 2024 8:05 PM GMT
SOLANA BEACH, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will